Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Frontiers in Pharmacology|September 9, 2020
Antimicrobial Peptide Reverses ABCB1-Mediated Chemotherapeutic Drug ResistanceXiaofang Luo, Qiu-Xu Teng, Jin-Yun Dong, et al.
Frontiers in Oncology|November 9, 2020
Sapitinib Reverses Anticancer Drug Resistance in Colon Cancer Cells Overexpressing the ABCB1 TransporterHai-Ling Gao, Pranav Gupta, Qingbin Cui, et al.
Frontiers in Oncology|June 2, 2020
M3814, a DNA-PK Inhibitor, Modulates ABCG2-Mediated Multidrug Resistance in Lung Cancer CellsZhuo-Xun Wu, Zheng Peng, Yuqi Yang, et al.
Frontiers in Cell and Developmental Biology|January 11, 2021
Establishment and Characterization of a Topotecan Resistant Non-small Cell Lung Cancer NCI-H460/TPT10 Cell LineZi-Ning Lei, Qiu-Xu Teng, Wei Zhang, et al.
Cancers|September 28, 2021
VKNG-1 Antagonizes ABCG2-Mediated Multidrug Resistance via p-AKT and Bcl-2 Pathway in Colon Cancer: In Vitro and In Vivo StudySilpa Narayanan, Ying-Fang Fan, Nehaben A Gujarati, et al.
European Journal of Pharmacology|September 3, 2019
Derivative of 5-cyano-6-phenylpyrimidin antagonizes ABCB1- and ABCG2-mediated multidrug resistanceJing-Quan Wang, Bo Wang, Zi-Ning Lei, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 10, 2024
Overexpression of ABCC1 and ABCG2 confers resistance to talazoparib, a poly (ADP-Ribose) polymerase inhibitorQiu-Xu Teng, Zi-Ning Lei, Jing-Quan Wang, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 17, 2024
ABCB1-dependent collateral sensitivity of multidrug-resistant colorectal cancer cells to the survivin inhibitor MX106-4CZi-Ning Lei, Najah Albadari, Qiu-Xu Teng, et al.
Pageof 6